RESUMEN

Melanocytes are static, minimally proliferative cells. This leaves them vulnerable in vitiligo. Yet upon malignant transformation, they form vicious tumors. This profound switch in physiology is accompanied by genetic change and is driven by environmental factors. If UV exposure in younger years supports malignant transformation and melanoma formation, it can likewise impart mutations on melanocytes that reduce their viability, to initiate vitiligo. A wide variety of microbes can influence these diametrically opposed outcomes before either disease takes hold. These microbes are vehicles of change that we are only beginning to study. Once a genetic modification occurs, there is a wide variety of immune cells ready to respond. Though it does not act alone, the T cell is among the most decisive responders in this process. The same biochemical process that offered the skin protection by producing melanin can become an Achilles heel for the cell when the T cells target melanosomal enzymes or, on occasion, neoantigens. T cells are precise, determined, and consequential when they strike. Here, we probe the relationship between the microbiome and its metabolites, epithelial integrity, and the activation of T cells that target benign and malignant melanocytes in vitiligo and melanoma.

Asunto(s)

Asunto(s)

RESUMEN

Paciente de 21 años, de sexo masculino, infectado por el VIH y que no sigue adecuadamente el tratamiento antirretroviral, que acude a consulta debido a una erupción papular en el tronco y las extremidades, acompañada de manera simultánea por manchas hipocrómicas en la espalda. El paciente estaba afebril y hemodinámicamente estable. En el estudio micológico de las muestras clínicas de diferentes lesiones se observaron levaduras compatibles con Malassezia. Se prescribió itraconazol por vía oral, con una excelente respuesta clínica. El hallazgo del mismo agente etiológico con 2 presentaciones clínicas diferentes en un solo paciente es poco habitual

A 21 year-old man, HIV infected, and with poor adherence to antiretroviral treatment, consulted us due to a papular rash on trunk and extremities, showing simultaneously hypochromic stains on his back. He was afebrile and hemodynamically stable. In the mycological study of the clinical samples taken from different lesions, yeasts compatible with Malassezia were observed. Oral itraconazole was prescribed, with an excellent clinical response. Finding the same etiolologic agent in 2 different clinical pictures on a single patient is extremely rare

Asunto(s)

Asunto(s)

RESUMEN

A 21 year-old man, HIV infected, and with poor adherence to antiretroviral treatment, consulted us due to a papular rash on trunk and extremities, showing simultaneously hypochromic stains on his back. He was afebrile and hemodynamically stable. In the mycological study of the clinical samples taken from different lesions, yeasts compatible with Malassezia were observed. Oral itraconazole was prescribed, with an excellent clinical response. Finding the same etiolologic agent in 2different clinical pictures on a single patient is extremely rare.

Asunto(s)

Asunto(s)

RESUMEN

INTRODUCTION: Phialophora sp. dematiaceous fungus frequently isolated from soil and organic debris from animals and plants. There have been no reports of nail involvement caused by this fungus. We report the case of a 77-year-old male with blackish-brown pigmentation involving a single finger for one year. The identification of the fungus was determined by macromorphological and micromorphological study of the colony and we discuss the clinical, microbiological, differential diagnosis, and treatment. COMMENT: We describe the first case of nail infection caused by Phialophora sp.

Asunto(s)

RESUMEN

OBJECTIVE: We report a typical case of earlobe lymphocytoma. METHOD: A case report and literature review are presented. RESULTS: A 10-year-old girl presented with a blue-coloured earlobe. A diagnosis of Lyme disease was confirmed by serological tests. Lyme borreliosis is the most common tick-borne disease in the northern hemisphere. It is caused by the spirochete Borrelia burgdorferi sensu lato. The patient was successfully treated with antibiotics. CONCLUSION: The diagnostic process and ENT symptomatology of Lyme disease and borrelial lymphocytoma are summarised and discussed.

Asunto(s)

Asunto(s)

RESUMEN

Aunque la pitiriasis versicolor (PV) es la única enfermedad humana en la que el rol etiológico de las levaduras Malassezia está plenamente establecido, permanece como objeto de controversia cuál (o cuáles) es la especie implicada. La mayoría de los estudios llevados a cabo en estos últimos años apoyan nuestra hipótesis, expuesta ya en 1999, indicando que M. globosa es la especie predominante en las lesiones de PV, al menos en los climas templados. La confirmación de esta hipótesis podría ayudar a comprender las condiciones, todavía poco claras, que inducen la transformación de esta levadura de su forma saprofita presente en la piel sana, a la parasitaria, caracterizada por la formación de pseudomicelio, y ayudarían también a establecer las mejores medidas terapéuticas. Por otro lado, el aislamiento de otra especie, M. furfur, que parece predominar en regiones tropicales, podría plantear la posibilidad de un segundo agente etiológico confinado a ciertas áreas geográficas, como acontece en algunas otras micosis humanas (AU)

Although pityriasis versicolor is the only human disease for which Malassezia yeasts have been fully established as pathogens, it is still not clear which species are implicated. Most studies carried out in recent years support our hypothesis —proposed in 1999— that Malassezia globos a is the predominant species in pityriasis versicolor lesions, at least in temperate climates. Confirmation of this hypothesis could help us understand the conditions, as yet unclear, that induce transformation of this yeast from the saprophytic form present in healthy skin to the parasitic form, characterized by the formation of pseudomycelium, and could also guide therapy. In addition, isolation of another species, Malassezia furfur, which seems to be predominant in the tropics, raises the possibility of a second etiologic agent confined to certain areas, as occurs with some other human mycoses (AU)

Asunto(s)

Asunto(s)

Asunto(s)

Asunto(s)

RESUMEN

Skin problems are commonly encountered during and after travel. Because of increasing travel and tourism to remote and previously unvisited areas, it is likely that these and other dermatologic conditions will continue to be frequent problems observed in travelers. For the nondermatologist, recognition of many of the commonly encountered skin problems can be facilitated by following the lesion-oriented approach outlined in this article.

Asunto(s)

Asunto(s)

RESUMEN

BACKGROUND: African tick-bite fever is caused by R. africae. All cases reported to date in France have occurred among patients who came from southern Africa, the endemic zone. We report the first case, to our knowledge, of a patient infected in France. CASE REPORT: A 69-year-old white man who had never left France developed fever and 3 "black spots" on the legs with lymphangitis and enlarged nodes. The clinically suspected diagnosis was confirmed by positive serology reactions to R. africae. As cross immunity with R. conorii can occur, the diagnosis was further confirmed by western blot for R. africae and by the persistence of the reaction after adsorption of the R. conorii serum. DISCUSSION: African tick-bite fever was identified as a clinical entity different from Mediterranean spotted fever by Kelly in 1992 who demonstrated the causal role of R. africae. The typical clinical presentation associates fever, several black spots, lymphangitis and multiple node enlargement. The serological diagnosis is difficult owing to cross immunity with R. conorii. Western blot and polymerase chain reaction are required for definitive diagnosis. In our case, the infection was probably due to a R. africae imported into France in the luggage of the patient's daughter who had spent 3 months in Zimbabwe.

Asunto(s)

Asunto(s)

Asunto(s)

Asunto(s)

RESUMEN

The diagnosis of fungal keratitis can be difficult and is often delayed. The distinction between moniliaceous and dematiaceous (pigmented) keratomycoses is not commonly possible on clinical examination. We report a case of a Curvularia lunata fungal keratitis in a 40-year-old patient who presented with diffuse brown pigmentation throughout the ulcer bed. Histologic staining and growth on Sabourad's dextrose agar demonstrated the brown pigmentation characteristic of this pigmented fungus. We call attention to this clinical pigmentation as a helpful clue in the detection of dematiaceous fungal keratitis.

Asunto(s)